Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,571 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Subsequent chemotherapy with paclitaxel plus cetuximab-based chemotherapy following immune checkpoint inhibitor in recurrent or metastatic squamous cell carcinoma of the head and neck.
Tanaka H, Enokida T, Okano S, Fujisawa T, Tanaka N, Takeshita N, Onaga R, Hoshi Y, Wada A, Sato M, Ueda Y, Tahara M. Tanaka H, et al. Among authors: wada a. Front Oncol. 2023 Nov 21;13:1221352. doi: 10.3389/fonc.2023.1221352. eCollection 2023. Front Oncol. 2023. PMID: 38074688 Free PMC article.
Induction chemotherapy with paclitaxel, carboplatin and cetuximab for locoregionally advanced nasopharyngeal carcinoma: A single-center, retrospective study.
Takeshita N, Enokida T, Okano S, Fujisawa T, Wada A, Sato M, Tanaka H, Tanaka N, Motegi A, Zenda S, Akimoto T, Tahara M. Takeshita N, et al. Among authors: wada a. Front Oncol. 2022 Aug 11;12:951387. doi: 10.3389/fonc.2022.951387. eCollection 2022. Front Oncol. 2022. PMID: 36033502 Free PMC article.
Potential efficacy of local therapy for progressive lesions after nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Sato M, Enokida T, Wada A, Okano S, Tanaka H, Fujisawa T, Ueda Y, Motegi A, Shinozaki T, Takeshita N, Tanaka N, Zenda S, Matsuura K, Akimoto T, Hayashi R, Tahara M. Sato M, et al. Among authors: wada a. Int J Clin Oncol. 2023 Aug;28(8):1023-1032. doi: 10.1007/s10147-023-02351-9. Epub 2023 Jun 21. Int J Clin Oncol. 2023. PMID: 37344738
Combination chemotherapy with taxane and platinum in patients with salivary gland carcinoma: a retrospective study of docetaxel plus cisplatin and paclitaxel plus carboplatin.
Onaga R, Enokida T, Ito K, Ueda Y, Okano S, Fujisawa T, Wada A, Sato M, Tanaka H, Takeshita N, Tanaka N, Hoshi Y, Tahara M. Onaga R, et al. Among authors: wada a. Front Oncol. 2023 Jun 15;13:1185198. doi: 10.3389/fonc.2023.1185198. eCollection 2023. Front Oncol. 2023. PMID: 37397398 Free PMC article.
Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN).
Takeshita N, Enokida T, Okano S, Fujisawa T, Wada A, Sato M, Tanaka H, Tanaka N, Onaga R, Hoshi Y, Sakashita S, Ishii G, Tahara M. Takeshita N, et al. Among authors: wada a. Oral Oncol. 2023 Dec;147:106615. doi: 10.1016/j.oraloncology.2023.106615. Epub 2023 Nov 4. Oral Oncol. 2023. PMID: 37931493
Surgical Strategy for Squamous Cell Carcinoma of the External Auditory Canal: Management of Locally Advanced Cases with Skull Base Involvement.
Goto S, Nishio N, Iwami K, Yoshida T, Maruo T, Mukoyama N, Tsuzuki H, Yokoi S, Wada A, Hiramatsu M, Hayashi Y, Kamei Y, Fujii M, Sone M, Fujimoto Y. Goto S, et al. Among authors: wada a. J Neurol Surg B Skull Base. 2022 Feb 4;84(1):69-78. doi: 10.1055/a-1733-2585. eCollection 2023 Feb. J Neurol Surg B Skull Base. 2022. PMID: 36743718 Free PMC article.
1,571 results